Paper35722356
Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.
Peng D and 7 others. Ann Transl Med, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report. Papers, record 35722356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35722356
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23179561 | Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis. | J Antimicrob Chemother | 2013 | https://conductscience.org/library/papers/23179561 | PubMed |
| 2 | 24749079 | Global survey of polymyxin use: A call for international guidelines. | J Glob Antimicrob Resist | 2013 | https://conductscience.org/library/papers/24749079 | PubMed |
| 3 | 30582435 | Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients. | Expert Opin Drug Metab Toxicol | 2019 | https://conductscience.org/library/papers/30582435 | PubMed |
| 4 | 27474468 | Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration. | Int J Antimicrob Agents | 2016 | https://conductscience.org/library/papers/27474468 | PubMed |
| 5 | 20028824 | Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20028824 | PubMed |
| 6 | 29334366 | Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy. | Chemotherapy | 2018 | https://conductscience.org/library/papers/29334366 | PubMed |
| 7 | 32383061 | Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper. | Intensive Care Med | 2020 | https://conductscience.org/library/papers/32383061 | PubMed |
| 8 | 32547394 | Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32547394 | PubMed |
| 9 | 27553752 | Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature. | Clin Ther | 2016 | https://conductscience.org/library/papers/27553752 | PubMed |
| 10 | 28275006 | Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes. | Clin Microbiol Rev | 2017 | https://conductscience.org/library/papers/28275006 | PubMed |
| 11 | 22615285 | Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22615285 | PubMed |
| 12 | 31767718 | Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST). | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31767718 | PubMed |
| 13 | 31637180 | Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration. | J Transl Int Med | 2019 | https://conductscience.org/library/papers/31637180 | PubMed |
| 14 | 33832018 | [Multi-disciplinary expert consensus on the optimal clinical use of the polymyxins in China]. | Zhonghua Jie He He Hu Xi Za Zhi | 2021 | https://conductscience.org/library/papers/33832018 | PubMed |
| 15 | 31764007 | Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter? | Curr Opin Anaesthesiol | 2020 | https://conductscience.org/library/papers/31764007 | PubMed |
| 16 | 28628170 | Recent advances and perspectives in the design and development of polymyxins. | Nat Prod Rep | 2017 | https://conductscience.org/library/papers/28628170 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40246790 | A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/40246790 | PubMed |
| 39367501 | A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation. | Crit Care | 2024 | https://conductscience.org/library/papers/39367501 | PubMed |
| 38974043 | Polymyxins: recent advances and challenges. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38974043 | PubMed |
| 37518089 | Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial - a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial. | BMJ Open | 2023 | https://conductscience.org/library/papers/37518089 | PubMed |
| 36978342 | Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36978342 | PubMed |
| 36978303 | Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36978303 | PubMed |
| 36643845 | Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36643845 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35722356
GET https://conductscience.org/api/papers/v1/35722356/authors